| Full Name | Milan Optique Inc |
|---|---|
| Type | Facility |
| Speciality | Optometrist |
| Location | 83 5 Ave, Brooklyn, New York |
| Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013235373 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | (* (Not Available)) | Primary |
| 156FX1800X | Technician/technologist - Optician | (* (Not Available)) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Milan Optique Inc 83 5 Ave, Brooklyn, NY 11217 Ph: (718) 636-4526 | Milan Optique Inc 83 5 Ave, Brooklyn, NY 11217 Ph: (718) 636-4526 |
News Archive
CEVEC Pharmaceuticals, the developer of a novel human protein expression system derived from amniocytes, announced today the signing of a co-exclusive worldwide licensing agreement with Life Technologies Corporation, a leading provider of innovative life science solutions based in Carlsbad, California. Under the terms of the agreement, Life Technologies and CEVEC will co-operate to offer optimized expression kits based on CEVEC's proprietary CAP-T cells to the global life science research community.
"Many interesting research questions now lie ahead. But most urgent will be the assessment of the practical impact of these findings and their public health importance in generalised epidemics," according to a Lancet editorial about last week's release of study results showing early HIV treatment dramatically reduces transmission risk.
SMT Research and Development, Ltd., a privately held company, announced that it has completed its first two clinical cases using the Shimon Embolic Filter [SHEF] (TM). SMT R&D developed a novel technology for brain protection (Neuroprotection) from stroke complication hazards arising from invasive cardiology procedures and heart surgery.
Although observational studies have suggested that losartan, a drug used primarily for the treatment of hypertension, may be associated with an increased risk of death among patients with heart failure compared with other medications in the same class of drugs (angiotensin II receptor blockers [ARBs]), an analysis that included nearly 6,500 patients found that overall, use of losartan was not associated with increased all-cause death or cardiovascular death compared with use of the ARB candesartan, according to a study in the April 11 issue of JAMA.
Inflammation, cell division and cell differentiation that occur during skeletal muscle regeneration may provide an ideal environment for the highly malignant tumor, rhabdomyosarcoma to arise. These are the findings from a Nationwide Children's Hospital study that examined rhabdomyosarcoma growth in mouse models of muscular dystrophy.
› Verified 9 days ago
Dr. Irida Llambiri, OPTOMETRY DOCTOR Optometrist Medicare: Accepting Medicare Assignments Practice Location: 586 President St, Suite B, Brooklyn, NY 11215 Phone: 718-438-5600 | |
Effie Tatakis, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 2172 E 38th St, Brooklyn, NY 11234 Phone: 718-434-0711 | |
Sheepshead Bay Vision Center Llc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1607 Sheepshead Bay Rd, Brooklyn, NY 11235 Phone: 718-934-2366 Fax: 718-934-2366 | |
Paula Nutis Optometry, Pllc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 360 Gateway Dr, Brooklyn, NY 11239 Phone: 718-348-9387 | |
Vision Boutique Inc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 8503 20th Ave, Brooklyn, NY 11214 Phone: 718-513-0999 | |
Jenny Bartov, OD, MS Optometrist Medicare: Medicare Enrolled Practice Location: 1410 Avenue S Apt 5h, Brooklyn, NY 11229 Phone: 917-363-3697 | |
Dr. Michelle Yudina, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1316 Kings Hwy, Brooklyn, NY 11229 Phone: 718-489-1586 |